市場調査レポート
商品コード
1389672

ELISA診断検査市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲:採用、検査タイプ、用途、エンドユーザー、地域別

ELISA Diagnostic Test Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption, Test Type, Application, End User, and Geography

出版日: | 発行: The Insight Partners | ページ情報: 英文 199 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
ELISA診断検査市場規模・予測、世界・地域シェア、動向、成長機会分析レポート対象範囲:採用、検査タイプ、用途、エンドユーザー、地域別
出版日: 2023年11月02日
発行: The Insight Partners
ページ情報: 英文 199 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ELISA診断検査市場は、2022年の12億8,549万米ドルから2030年には22億7,123万米ドルに成長すると予測され、2022年から2030年までのCAGRは7.37%と推定されます。市場開拓の主な原動力となっているのは、動物間での感染症の増加と、人への感染症の発生率の増加です。

酵素結合免疫吸着測定法(ELISA)は、患者の血液中の抗体を検出・測定する検査法です。この検査は、患者が特定の感染症に関連する抗体を持っているかどうかを判定するために使用できます。ELISA検査は、エイズを引き起こすHIV、ライム病、悪性貧血、ロタウイルスなどの診断に使用されます。ELISAキットは、サンプルや培養物中の特定のターゲットを迅速、簡便、正確に検出・定量できる貴重な調査ツールです。市販のELISAキットには、プレコートプレート、捕捉/検出抗体、標準品、緩衝液、その他必要な試薬が含まれています。各キットは、正確性、精度、感度、特異性、再現性を保証するために、厳格なバリデーションと安定性試験を受けています。

革新的な製品の発売がELISA診断検査市場にチャンスをもたらします。

ELISA法は、柔軟性、感度、使いやすさなど様々な利点があり、最も人気のある免疫測定法の一つです。また、ELISA検査キットの低コストとハイスループット検査に伴う多面的な適用性により、さまざまな研究やIVDの要件に理想的なソリューションとなっています。低コストの適用性により、検査キットの製品革新はヒトおよび動物研究の需要を高めています。また、メーカー各社は自社設備を備えたELISA検査キットの開発に注力しています。

Innovative Research社は、凝固因子、生物種、抗体の同定に幅広い選択性を持つELISAキットを販売しています。「ヒト血液凝固第IX因子キット」もその一つです。ヒト凝固第IX因子抗原アッセイは、ヒト血漿中の全IX因子抗原の定量を目的としています。このキットは研究目的にのみ使用することが推奨され、試薬は最大96の臨床検査に利用することができます。

さらに、COVID-19の大流行の中、各メーカーがELISA検査の革新的な製品を発売したことで、ヒトへのELISA検査の普及が加速しています。

2022年12月、Pictor Limitedは「PictArray SARS-CoV-2抗体検査」の新製品発表を行っています。この新製品はCOVID-19ウイルスに関連する感染を検出し、得られた臨床結果は患者や医師がSARS-CoV-2感染症の治療や管理を行う際に役立ちます。メーカーによる革新的なELISA検査キットの発売は、低コストで多面的な応用が可能で、さまざまな生物種に関連する多様な感染症の診断に効果的な臨床結果を提供することが期待されます。このように、革新的な製品の発売は、長期的にはメーカーに有利な機会を提供すると思われます。

市場動向

ELISAベースの手順の進歩

ELISAを用いた体外診断(IVD)は、世界市場で大きな注目を集めています。さまざまな分野の研究者が、磁気ビーズ、紙ベースのプラットフォーム、ナノ材料などの技術を通じて、ELISAベースの手順の開発と応用に魅力を感じています。技術ベースのELISAキットの他の例としては、デジタルELISA、マルチプレックスELISA、単一分子ELISA、ナノ粒子ベースELISA、スマートフォンベースELISAなどがあります。また、迅速かつ効率的な臨床結果を得るために、各社は複数の技術に基づくELISA検査キットを発売しています。AMP'D ELISAシグナル増幅システム」は、Enzo Life Sciences, Inc.が製造しています。AMP'Dテクノロジーは、1つの増幅キットでサンドイッチELISAテストタイプの感度を効率的に向上させ、高感度を提供します。

Cell Signaling Technology, Inc.が設計した"PathScan Phospho-RSK1(Ser380)Sandwich ELISA Kit"も、テクノロジーを駆使したELISA検査キット製品の一例です。このような高度な技術に基づくELISA検査キット製品は、獣医やヒトに関連する感染症や疾病の原因となる様々な種を検出するために、将来的に獣医師による高い需要が見込まれます。したがって、ELISAベースの手順の進歩は、2020~2030年のELISA診断検査市場の成長を強化すると予想されます。

用途別の洞察

用途別では、ELISA診断検査市場は自己免疫疾患、感染症、がん診断、タンパク質定量、その他に分類されます。感染症分野は2022年に市場で最大のシェアを占め、2022-2030年の市場CAGRは8.43%と最も高くなると予測されています。ELISAは、免疫学において抗体や抗原を検出し、アレルギー検査や自己免疫疾患の診断を行うための強力な技術です。自己免疫疾患やウイルス性疾患(HIV、STI、B型肝炎など)の罹患率が高齢化、人口動態やライフスタイルの変化により世界中で増加していることが、世界のELISA診断検査市場の成長を促進しています。2023年にNational Stem Cell Foundationが発表した統計によると、自己免疫疾患は80種類以上の疾病に罹患しており、世界人口の4%近くが罹患しています。最も一般的な自己免疫疾患は、1型糖尿病、多発性硬化症、関節リウマチ、ループス、クローン病、乾癬、強皮症などです。米国では、自己免疫疾患は慢性疾患の原因として3番目に多いです。まれではあるが、これらの疾患を合わせると、米国人口の5%から8%が罹患しています。例えば、2022年5月にPubMed Centralで発表された論文によると、自己免疫性水疱症(AIBD)特異的抗体の従来の血清学的検出では、組織基質を用いた最初のスクリーニングに続いて、ELISAなどの抗原特異的アッセイが行われます。

さらに、次世代免疫診断プラットフォームの開発など、様々な技術的進歩が市場の成長を促進すると予想されています。

検査タイプ別に見ると、サンドイッチELISA、間接ELISA、競合ELISA、マルチプル&ポータブルELISAに分類されます。2022年の市場シェアは間接ELISAが大きく、2022~2030年のCAGRは同セグメントが高いと予測されます。

ELISA診断検査市場は、エンドユーザー別に病院・診断センター、製薬・バイオテクノロジー企業、動物病院・診断研究所、その他に分類されます。病院&診断センターセグメントが2020-2030年の市場シェアで最大を占めました。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要洞察
  • ELISA診断検査市場:地域別

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 ELISA診断検査市場情勢

  • PEST分析
    • PEST分析

第5章 ELISA診断検査市場:主要産業力学

  • 市場促進要因
    • 動物における感染症の増加
    • ヒト感染症の増加
  • 主な市場抑制要因
    • 製品回収の発生
  • 主な市場機会
    • 革新的な製品の上市
  • 今後の動向
    • ELISAベースの手順の進歩

第6章 ELISA診断検査市場:世界市場分析

  • ELISA診断検査市場の収益、2022年~2030年

第7章 ELISA診断検査の世界市場 - 収益と2030年までの予測:採用別

  • ELISA診断検査市場:採用別2022年・2030年収益シェア(%)
  • ヒト
  • 動物用

第8章 ELISA診断検査の世界市場 - 収益と2030年までの予測:検査タイプ別

  • ELISA診断検査市場:検査タイプ別2022年・2030年収益シェア(%)
  • サンドイッチELISA
  • 間接法ELISA
  • 競合ELISA
  • マルチプル&ポータブルELISA

第9章 ELISA診断検査の世界市場 - 収益と2030年までの予測:用途別

  • ELISA診断検査市場:用途別2022年・2030年収益シェア(%)
  • 自己免疫疾患
  • 感染症
  • がん診断
  • タンパク質定量
  • その他

第10章 ELISA診断検査の世界市場 - 収益と2030年までの予測:エンドユーザー別

  • ELISA診断検査市場:エンドユーザー別2022年・2030年収益シェア(%)
  • 病院・診断センター
  • 製薬・バイオテクノロジー企業
  • 動物病院・診断研究所
  • その他

第11章 ELISA診断検査市場 - 収益と2030年までの予測:地域別分析

  • 北米
  • 欧州
  • アジア太平洋
  • 中東・アフリカ
  • 中南米

第12章 ELISA診断検査市場-業界情勢

  • ELISA診断検査市場の成長戦略
  • 有機的成長戦略
  • 無機的成長戦略

第13章 企業プロファイル

  • Bio-Rad Laboratories Inc
  • Idexx Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Danaher Corp
  • Innovative Diagnostics SAS
  • Pictor Ltd
  • DiaSorin SpA
  • Elabscience Biotechnology Inc
  • Bio-Techne Corp

第14章 付録

図表

List Of Tables

  • Table 1. ELISA Diagnostic Test Market Segmentation
  • Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
  • Table 3. North America US ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America US ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Following is a list of zoonotic disease outbreaks spread between animals and people.
  • Table 8. US ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Germany ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Germany ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. France ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. France ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. UK ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. UK ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Italy ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Italy ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Italy ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Spain ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Spain ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Spain ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Rest of Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Rest of Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Rest of Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Asia Pacific ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Asia Pacific ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. China ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. China ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Japan ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Japan ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. India ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. India ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Australia ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Australia ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. South Korea ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. South Korea ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Rest of Asia Pacific ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East & Africa ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Middle East & Africa ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Middle East & Africa ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South Africa ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South Africa ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Saudi Arabia ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Saudi Arabia ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. UAE ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. UAE ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. UAE ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. South & Central America ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South & Central America ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. South & Central America ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Brazil ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Brazil ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Brazil ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Argentina ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Argentina ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Argentina ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of South & Central America ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Rest of South & Central America ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Rest of South & Central America ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Recent Organic Growth Strategies in ELISA diagnostics Test Market
  • Table 113. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
  • Table 114. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

  • Figure 1. ELISA Diagnostic Test Market Segmentation, By Geography
  • Figure 2. PEST Analysis
  • Figure 3. ELISA Diagnostic Test Market: Key Industry Dynamics
  • Figure 4. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
  • Figure 5. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
  • Figure 6. Global ELISA Diagnostic Tests Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • Figure 8. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 11. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 22. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. North America: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 27. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 29. US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 35. Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. Asia Pacific: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 42. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Asia Pacific: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 44. China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Middle East & Africa: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 51. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Middle East & Africa: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 53. South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. South & Central America: ELISA Diagnostic Tests Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 58. South & Central America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. South & Central America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 60. Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 63. Growth Strategies in ELISA diagnostics test Market
目次
Product Code: TIPRE00030120

The ELISA Diagnostic Test Market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and the increasing incidence of human infections are the key driving factors behind the market development.

An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient's blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.

Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.

Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.

Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.

In December 2022, Pictor Limited announced a new product launch of the "PictArray SARS-CoV-2 Antibody Test," which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Market Trend

Advancements in ELISA-Based Procedures

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030.

Application-Based Insights

In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world's population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.

Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.

Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.

The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the ELISA diagnostic test market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global ELISA diagnostic test market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global ELISA diagnostic test market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 Global ELISA Diagnostic Tests Market - by Adoption
    • 1.2.2 Global ELISA Diagnostic Tests Market - by Test Type
    • 1.2.3 Global ELISA Diagnostic Tests Market - by Application
    • 1.2.4 Global ELISA Diagnostic Tests Market - by End User
    • 1.2.5 Global ELISA Diagnostic Tests Market - by Region

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 ELISA Diagnostic Test Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. ELISA Diagnostic Test Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 PEST Analysis

5. ELISA Diagnostic Test Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Infectious Diseases Among Animals
    • 5.1.2 Increasing Incidence of Human Infections
  • 5.2 Key Market Restraints
    • 5.2.1 Incidents of Product Recalls
  • 5.3 Key Market Opportunities
    • 5.3.1 Innovative Product Launches
  • 5.4 Future Trends
    • 5.4.1 Advancements in ELISA-Based Procedures

6. ELISA Diagnostic Tests Market - Global Market Analysis

  • 6.1 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

7. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

  • 7.1 Overview
  • 7.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • 7.3 Human
    • 7.3.1 Overview
    • 7.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Veterinary
    • 7.4.1 Overview
    • 7.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Sandwich ELISA
    • 8.3.1 Overview
    • 8.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Indirect ELISA
    • 8.4.1 Overview
    • 8.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Competitive ELISA
    • 8.5.1 Overview
    • 8.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Multiple & Portable ELISA
    • 8.6.1 Overview
    • 8.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Autoimmune Diseases
    • 9.3.1 Overview
    • 9.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Infectious Disease
    • 9.4.1 Overview
    • 9.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Cancer Diagnosis
    • 9.5.1 Overview
    • 9.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Protein Quantification
    • 9.6.1 Overview
    • 9.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals & Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical & Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Veterinary Hospitals & Diagnostic Laboratories
    • 10.5.1 Overview
    • 10.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

11. ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 11.1 North America: ELISA Diagnostic Tests Market
    • 11.1.1 Overview
    • 11.1.2 North America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.1.4 North America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.1.5 North America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.1.6 North America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.1.7 North America: ELISA Diagnostic Tests Market, by Country
      • 11.1.7.1 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.1.7.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.7.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.1.7.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.7.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.3 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.1.7.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.7.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe: ELISA Diagnostic Tests Market
    • 11.2.1 Overview
    • 11.2.2 Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.2.3 Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.2.4 Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.2.5 Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.2.6 Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.2.7 Europe: ELISA Diagnostic Tests Market, by Country
      • 11.2.7.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.3 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.4 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.5 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.6 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific: ELISA Diagnostic Tests Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.3.7 Asia Pacific: ELISA Diagnostic Tests Market, by Country
      • 11.3.7.1 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.3 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.4 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
        • 11.3.7.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.5 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa: ELISA Diagnostic Tests Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.4.6 Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.4.7 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
      • 11.4.7.1 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.7.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.7.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.3 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
        • 11.4.7.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America: ELISA Diagnostic Tests Market
    • 11.5.1 Overview
    • 11.5.2 South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.5.3 South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.5.7 South & Central America: ELISA Diagnostic Tests Market, by Country
      • 11.5.7.1 Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.5.7.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.7.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.2 Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.5.7.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.7.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.3 Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.5.7.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.7.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

12. ELISA Diagnostics Test Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in ELISA diagnostics test Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bio-Rad Laboratories Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Idexx Laboratories Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 F. Hoffmann-La Roche Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Thermo Fisher Scientific Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Abbott Laboratories
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Danaher Corp
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Innovative Diagnostics SAS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Pictor Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 DiaSorin SpA
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Elabscience Biotechnology Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 SWOT Analysis
    • 13.10.5 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms